Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?

Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J.

Am J Med. 2003 Dec 15;115(9):715-20.

PMID:
14693324
2.

An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.

Tannenbaum H, Bombardier C, Davis P, Russell AS; Third Canadian Consensus Conference Group.

J Rheumatol. 2006 Jan;33(1):140-57. Epub 2005 Dec 1. Erratum in: J Rheumatol. 2006 Apr;33(4):829. J Rheumatol. 2006 Feb;33(2):440.

PMID:
16331802
3.
4.

Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention.

Bardou M, Barkun AN.

Joint Bone Spine. 2010 Jan;77(1):6-12. doi: 10.1016/j.jbspin.2009.11.008. Epub 2009 Dec 21. Review.

PMID:
20022539
5.

Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Savage R.

Drugs Aging. 2005;22(3):185-200. Review.

PMID:
15813652
6.
7.
8.
9.

Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.

Lazzaroni M, Bianchi Porro G.

Aliment Pharmacol Ther. 2004 Jul;20 Suppl 2:48-58. Review.

10.

Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.

Dajani EZ, Islam K.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:117-33. Review.

11.

[Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].

Lanas A.

Rev Gastroenterol Mex. 2004 Oct-Dec;69(4):251-60. Review. Spanish.

PMID:
15765979
13.

Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug.

Suleyman H, Cadirci E, Albayrak A, Halici Z.

Curr Med Chem. 2008;15(3):278-83. Review.

PMID:
18333314
14.

Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.

Lehmann FS, Beglinger C.

Curr Top Med Chem. 2005;5(5):449-64. Review.

PMID:
15974940
15.

Potential cardiovascular effects of COX-2 selective nonsteroidal antiinflammatory drugs.

Fowles RE.

J Pain Palliat Care Pharmacother. 2003;17(2):27-50. Review.

PMID:
14649387
16.
17.

[Therapy with nonsteroidal anti-inflammatory drugs].

Bauer H, Märker-Hermann E.

Orthopade. 2003 Dec;32(12):1088-94. Review. German.

PMID:
14655005
18.

What is the most effective therapy for preventing NSAID-induced gastropathy?

Chandramouli J.

J Pain Palliat Care Pharmacother. 2002;16(2):23-36. Review.

PMID:
14650458
19.

[New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Stichtenoth DO, Zeidler H, Frölich JC.

Med Klin (Munich). 1998 Jul 15;93(7):407-15. Review. German.

PMID:
9711054
20.

Controversies in COX-2 selective inhibition.

Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH.

J Rheumatol. 2002 Jul;29(7):1501-10. Review. No abstract available.

PMID:
12136912

Supplemental Content

Support Center